Maximizing treatment efficacy through patient stratification in neuropathic pain trials (2022)
Attributed to:
Using human IPSC derived nociceptors as a cellular model to investigate and therapeutically target Nav1.7
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41582-022-00741-7
PubMed Identifier: 36400867
Publication URI: http://europepmc.org/abstract/MED/36400867
Type: Journal Article/Review
Parent Publication: Nature Reviews Neurology
Issue: 1
ISSN: 1759-4758